The Spector of Malignancy and Criteria for Cell Lines as Substrates for Vaccines

  • Jonas Salk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 118)


While preparing for this meeting, I felt like Rip van Winkle awakening from a 20-year sleep to discover how much has happened and has been learned in the interim.


Influenza Virus Tumorigenic Cell Cell Substrate Chick Embryo Extract Life Span Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Francis, T. Jr., Salk, J. A simplified procedure for the concentration and purification of influenza virus. Science 96: 499–500. 1942.PubMedCrossRefGoogle Scholar
  2. 2.
    Commission on Influenza: A clinical evaluation of vaccination against influenca. J. Am. Med. Assoc. 124:982–985. 1944.Google Scholar
  3. 3.
    Salk, J.E., Bennett, B.L., Lewis, L.J., et al. Studies in human subjects on active immunization against poliomyelitis. 1. A preliminary report of experiments in progress. Ibid. 151:1081–1098. 1953.Google Scholar
  4. 4.
    Salk, J.E., Contakos, M., Laurent, A.M.,et al. Use of adjuvants in studies on influenza immunization. 3. Degree of persistence of antibody in human subjects two years after vaccination. Ibid. 151:1169–1175. 1953.Google Scholar
  5. 5.
    Beebe, G.W., Simon, A.H., Vivona, S. Follow-up study on army personnel who received adjuvant influenza virus vaccine. Am. J. Med. Sci. 247:385–406. 1964.PubMedCrossRefGoogle Scholar
  6. 6.
    Beebe, F.W., Simon, A.H., Vivona, S. Long-term mortality follow-up of army recruits who received adjuvant influenza virus vaccine in 1951-1953. Am. J. Epidemiol. 95:337–346. 1972.PubMedGoogle Scholar
  7. 7.
    Salk, J. (Discussion Section). Poliomyelitis, Fourth International Poliomyelitis Conference. Edited for the International Poliomyelitis Congress. Philadelphia, J.B. Lippincott, 1958. pp. 289–290.Google Scholar
  8. 8.
    Salk, J., Ward, E.N. Some characteristics of a continuously propagating cell derived from monkey heart tissue. Science 126:1138–1139. 1957.CrossRefGoogle Scholar
  9. 9.
    Clausen, J.J. Syverton, J.T. Comparative chromosomal study of 31 cultured mammalian cell lines. J. Nat. Cancer Inst. 28: 117–145. 1962.PubMedGoogle Scholar
  10. 10.
    Greene, A.E., Coriell, L.L., Charney, J.A. Rapid cytotoxic antibody test to determine species of cell cultures. Ibid. 32:779–796. 1964.Google Scholar
  11. 11.
    Salk, J. Immunological paradoxes — theoretical considerations in the rejection or retention of grafts, tumors, and normal tissue. Ann. N.Y. Acad. Sci. 162:365–380. 1969.CrossRefGoogle Scholar
  12. 12.
    Deinhardt, F. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates. Cell Cultures for Virus Vaccine Production. NCI Monograph 29, Washington, DC, US Government Printing office. 1968. pp. 327–331.Google Scholar
  13. 13.
    Stevenson, R.E. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates — discussion. Ibid, pp. 33–334.Google Scholar
  14. 14.
    Moore, A.E. Evidence for oncogenic properties of heteroploid cell lines — discussion. Ibid, pp 291–292.Google Scholar
  15. 15.
    Petricciani, J. (paper in this volume).Google Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • Jonas Salk
    • 1
  1. 1.The Salk Institute for Biological StudiesSan DiegoUSA

Personalised recommendations